Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025? - MSN

W e recently compiled a list of the 10 Stocks Set to Explode in 2025. In this article, we are going to take a look at where TG Therapeutics, Inc. (NASDAQ:TGTX) stands against the other …

$3
OFF

TG Therapeutics, Inc. (TGTX) Stock Forecast For 2024, 2025, 2026.

2 weeks from now

Nov 18, 2024 · Tesla Shareholders Are Set To Have A Very Bad 2025. December 20, 2024. Amazon: $3 Trillion Is A Matter Of Time. December 20, 2024. ... TG Therapeutics, Inc. …

pandaforecast.com

$40.80
OFF

Tg Therapeutics Inc Stock Forecast, Predictions & Price Target

2 weeks from now

On average, Wall Street analysts predict. that Tg Therapeutics's share price could reach $40.80 by Nov 25, 2025. The average Tg Therapeutics stock price prediction forecasts a potential …

wallstreetzen.com

$29.74
OFF

Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers? - MSN

2 weeks from now

Higher earnings coupled with a positive outlook for 2025 sent TG Therapeutics Inc. (NASDAQ:TGTX) share prices rising by 7.48 percent on Tuesday to end at $29.74 apiece.

msn.com

8%
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TGTX Price Action: TG Therapeutics shares were up 7.8% at $29.85 at the time of publication, according to Benzinga Pro. Photo: Shutterstock. Market News and Data brought to …

benzinga.com

$25.86
OFF

TGTX’s Unexpected Surge: What’s Next? – BOVNews

2 weeks from now

Nov 6, 2024 · TG Therapeutics Inc common stock (TGTX) Stock Trading Recap. On Tuesday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $25.86 …

bovnews.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

2 hours ago · TG Therapeutics TGTX shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher-than-average number of …

yahoo.com

33%
OFF

All News For TGTX : TG Therapeutics - Zacks.com

2 weeks from now

Apr 30, 2024 · TG Therapeutics (TGTX) delivered earnings and revenue surprises of -133.33% and 15.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to …

zacks.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Nov 30, 2021 · Shares of biopharma outfit TG Therapeutics (TGTX-6.82%) are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the U.S. Food and Drug …

fool.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

15 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

FAQs about Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025? - MSN Coupon?

How much did TG Therapeutics (tgtx) lose?

While the company reported a net loss of $6.9 million during the quarter and $3.8 million for the first half of the year, TG Therapeutics, Inc. (NASDAQ:TGTX) logged a net loss of $47.6 million and $86.8 million for the three and six months ending June 30, 2023. ...

What happened to TG Therapeutics?

TG Therapeutics, despite its significant achievements, has also faced notable setbacks. The company's cancer drug Ukoniq was pulled from the market due to its ineffectiveness. ...

What is tgtx's current price target?

TGTX's current price target is $40.67. Learn why top analysts are making this stock forecast for TG Therapeutics at MarketBeat. ...

How much did TG Therapeutics make in 2024?

Before trading, TG Therapeutics announced it hit $310 million in revenues for the full year 2024, of which $103.6 million was registered in the fourth quarter alone. The figures beat projections, having pegged revenues to settle between $300 million to $305 million for 2024. ...

How will TG Therapeutics perform in 2025?

After the latest results, the nine analysts covering TG Therapeutics are now predicting revenues of US$540.9m in 2025. If met, this would reflect a sizeable 104% improvement in revenue compared to the last 12 months. Earnings are expected to improve, with TG Therapeutics forecast to report a statutory profit of US$1.01 per share. ...

Does TG Therapeutics (tgtx) have a repurchase program?

TG Therapeutics, Inc. (NASDAQ:TGTX) is making significant efforts to establish solid fundamentals for the company. During the second quarter of 2024, the company established a credit facility to pay its current debt and accelerate the initiation of a share repurchase program. ...